Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Anika Therapeutics, Inc. (ANIK)

Income Statement Business | Product | Geographic | Customer

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K/A10-K10-K10-K
Total revenues   [+]156.2147.8130.5114.6105.6113.4103.493.0
            Revenue growth  5.7%13.3%13.8%8.6%-6.9%9.7%11.2%-11.9%
Cost of goods sold  70.472.768.829.831.327.424.021.1
Gross profit  85.875.161.684.874.386.179.471.9
            Gross margin  54.9%50.8%47.3%74.0%70.4%75.9%76.8%77.4%
Selling, general and administrative  84.874.160.135.034.321.518.014.8
Research and development  28.227.323.416.718.218.810.79.0
Other operating expenses  -7.8-7.8-7.4-1.0    
EBITDA   [+]-12.7-12.0-8.439.227.750.054.351.9
            EBITDA margin  -8.1%-8.1%-6.4%34.2%26.2%44.1%52.6%55.8%
Depreciation  -1.1-0.96.14.04.93.32.62.7
EBITA  -11.6-11.1-14.535.222.746.751.749.2
            EBITA margin  -7.4%-7.5%-11.1%30.8%21.6%41.2%50.0%52.9%
Amortization of intangibles  7.87.4 1.01.01.01.11.1
EBIT   [+]-19.4-18.5-14.534.221.745.750.648.1
            EBIT margin  -12.4%-12.5%-11.1%29.9%20.6%40.3%49.0%51.8%
Non-recurring items   [+] -21.113.9     
Interest income, net   [+]0.7-0.2-0.31.91.50.50.30.1
Pre-tax income  -18.72.4-28.636.123.246.250.948.3
Income taxes  -3.9-1.7-4.68.94.514.418.317.5
            Tax rate  20.7% 16.2%24.7%19.3%31.1%36.0%36.3%
Net income  -14.94.1-24.027.218.731.832.530.8
            Net margin  -9.5%2.8%-18.4%23.7%17.7%28.1%31.5%33.1%
   
Basic EPS   [+]($1.02)$0.29($1.69)$1.93$1.30$2.18$2.22$2.06
Diluted EPS   [+]($1.02)$0.28($1.69)$1.89$1.27$2.11$2.15$2.01
   
Shares outstanding (basic)   [+]14.614.414.214.114.414.614.714.9
Shares outstanding (diluted)   [+]14.614.614.214.414.715.115.115.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy